UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PI3KC2α, a new spindle associated protein involved in genomic instability and tumorigenesis

European journal of cancer (1990), 2016-07, Vol.61, p.S75-S75

2016

Volltextzugriff (PDF)

PO-422 Development of an ALK lymphoma-derived autophagosomal and dendritic cells vaccine

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A396-A396

2018

Volltextzugriff (PDF)

IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing

Leukemia, 2009-11, Vol.23 (11), p.2102-2108

2009

Volltextzugriff (PDF)

The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1

Oncogenesis (New York, NY), 2013-04, Vol.2 (4), p.e43-e43

2013

Volltextzugriff (PDF)

Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing

Current opinion in genetics & development, 2013-04, Vol.10 (4), p.361-365

2013

Volltextzugriff (PDF)

300: Loss of PI3K-C2a promotes tumorigenesis and aneuploidy in breast cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S71-S71

2014

Volltextzugriff (PDF)

Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas

Clinical and experimental immunology, 2007-09, Vol.149 (3), p.504-512

2007

Volltextzugriff (PDF)

Mechanisms that promote and suppress chromosomal translocations in lymphocytes

Annual review of immunology, 2011-04, Vol.29 (1), p.319-350

2011

Volltextzugriff (PDF)

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma

Blood cancer journal (New York), 2014-10, Vol.4 (10), p.e249-e249

2014

Volltextzugriff (PDF)

1219PMaternal immunization against ALK as a weapon to fight neuroblastoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Maternal immunization against ALK as a weapon to fight neuroblastoma

Annals of oncology, 2019-10, Vol.30, p.v498

2019

Volltextzugriff (PDF)

1219P - Maternal immunization against ALK as a weapon to fight neuroblastoma

Annals of oncology, 2019-10, Vol.30, p.v498-v498

2019

Volltextzugriff (PDF)

874 ALK Inhibitors and Vaccination Against Anaplastic Lymphoma Kinase (ALK) Induce Potent Anti-tumor Activity Improving Overall Survival in Non Small Cell Lung Carcinoma (NSCLC)

European journal of cancer (1990), 2012-07, Vol.48, p.S211-S211

2012

Volltextzugriff (PDF)

1007 ORAL Efficacy of DNA Vaccination Against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lung Carcinoma (NSCLC)

European journal of cancer (1990), 2011, Vol.47, p.S99-S99

2011

Volltextzugriff (PDF)

9235 POSTER BCL2 Expression Correlates With Surface Immunoglobulin Levels and Prognosis in Follicular Lymphoma Patients

European journal of cancer (1990), 2011, Vol.47, p.S649-S649

2011

Volltextzugriff (PDF)

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

Nature medicine, 2005-06, Vol.11 (6), p.623-629

2005

Volltextzugriff (PDF)

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Oncogene, 2002-02, Vol.21 (7), p.1038-1047

2002

Volltextzugriff (PDF)

Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency

Oncogene, 2016-07, Vol.35 (29), p.3854-3865

2016

Volltextzugriff (PDF)

Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1

Oncotarget, 2016-05, Vol.7 (22), p.33316-33330

2016

Volltextzugriff (PDF)

The STAT3 isoforms [alpha] and [beta] have unique and specific functions

Nature immunology, 2004-04, Vol.5 (4), p.401

2004

Volltextzugriff (PDF)

Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization

Oncotarget, 2017-03, Vol.8 (12), p.18680-18698

2017

Volltextzugriff (PDF)

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

Blood, 2006-01, Vol.107 (2), p.689-697

2006

Volltextzugriff (PDF)

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Oncogene, 2002-02, Vol.21 (7), p.1038-1047

2002

Volltextzugriff (PDF)

Role of the F-box Protein Skp2 in Lymphomagenesis

Proceedings of the National Academy of Sciences - PNAS, 2001-02, Vol.98 (5), p.2515-2520

2001

Volltextzugriff (PDF)

BRAF gene is not mutated in plasma cell leukemia and multiple myeloma

Leukemia, 2003-11, Vol.17 (11), p.2238-2240

2003

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(100)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(51)
Humans
(50)
Animals
(27)
Biological And Medical Sciences
(22)
Medical Sciences
(20)
Mice
(20)
Female
(19)
Oncology
(18)
Aged
(13)
Middle Aged
(13)
Cell Biology
(12)
Hematology
(12)
Male
(12)
Biochemistry & Molecular Biology
(11)
Hematologic And Hematopoietic Diseases
(11)
Immunohistochemistry
(11)
Adult
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)
Hematology, Oncology And Palliative Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PI3KC2α, a new spindle associated protein involved in genomic instability and tumorigenesis

PO-422 Development of an ALK lymphoma-derived autophagosomal and dendritic cells vaccine

IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing

The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1

Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing

300: Loss of PI3K-C2a promotes tumorigenesis and aneuploidy in breast cancer

Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas

Mechanisms that promote and suppress chromosomal translocations in lymphocytes

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma

1219PMaternal immunization against ALK as a weapon to fight neuroblastoma

Maternal immunization against ALK as a weapon to fight neuroblastoma

1219P - Maternal immunization against ALK as a weapon to fight neuroblastoma

874 ALK Inhibitors and Vaccination Against Anaplastic Lymphoma Kinase (ALK) Induce Potent Anti-tumor Activity Improving Overall Survival in Non Small Cell Lung Carcinoma (NSCLC)

1007 ORAL Efficacy of DNA Vaccination Against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lung Carcinoma (NSCLC)

9235 POSTER BCL2 Expression Correlates With Surface Immunoglobulin Levels and Prognosis in Follicular Lymphoma Patients

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency

Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1

The STAT3 isoforms [alpha] and [beta] have unique and specific functions

Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Role of the F-box Protein Skp2 in Lymphomagenesis

BRAF gene is not mutated in plasma cell leukemia and multiple myeloma

Suchergebnisse filtern